Search research articles
Contact Us
Filters
Showing results (61-70 of 456) with videos related to
Page
of 46
Sort By:
Kidney International. Supplement
|
August 14, 2010
Potential of emerging immunosuppressive strategies to improve the posttransplant cardiovascular risk profile
Arjang Djamali, Carolynn E Pietrangeli, Robert D Gordon, et al.
Human Immunology
|
May 31, 2016
Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?
Marianne Delville, Béatrice Charreau, Marion Rabant, et al.
Medecine Sciences : M/S
|
November 15, 2006
[mTOR inhibitors: pleiotropic antiproliferative drugs]
Nicolas Pallet, Philippe Beaune, Eric Thervet, et al.
Clinical Transplants
|
June 24, 2011
Bortezomib alone fails to decrease donor specific anti-HLA antibodies: even after one year post-treatment
Rebecca Sberro-Soussan, Julien Zuberl, Caroline Suberbielle-Boissel, et al.
Transplantation
|
July 30, 2014
Diarrhea after kidney transplantation: a new look at a frequent symptom
Florence Aulagnon, Anne Scemla, Susan DeWolf, et al.
Transplantation Direct
|
December 28, 2020
COVID-19: A One-center Experience in Paris
Nathalie Chavarot, Catherine Fournier, Carole Burger, et al.
Lancet (London, England)
|
April 30, 2013
Diagnostic criteria for kidney transplant rejection: a call to action - Authors' reply
Alexandre Loupy, Carmen Lefaucheur, Denis Glotz, et al.
Nephrologie & Therapeutique
|
July 16, 2011
[Parvovirus B19 infection after kidney transplantation]
Albane Brodin-Sartorius, Yahia Mekki, Bénédicte Bloquel, et al.
Transplantation
|
May 29, 2004
Complications of protocol renal biopsy
Lazaro Capote Fereira, Alexandre Karras, Frank Martinez, et al.
Transplantation
|
November 30, 2005
Proteinuria following a switch from calcineurin inhibitors to sirolimus
Emmanuel Letavernier, Marie-Noëlle Pe'raldi, Antoine Pariente, et al.
Page
of 46
Search research articles
Search
Showing results (61-70 of 456) with videos related to
Sort By:
Page
of 46
Kidney International. Supplement
|
August 14, 2010
Potential of emerging immunosuppressive strategies to improve the posttransplant cardiovascular risk profile
Arjang Djamali, Carolynn E Pietrangeli, Robert D Gordon, et al.
Human Immunology
|
May 31, 2016
Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?
Marianne Delville, Béatrice Charreau, Marion Rabant, et al.
Medecine Sciences : M/S
|
November 15, 2006
[mTOR inhibitors: pleiotropic antiproliferative drugs]
Nicolas Pallet, Philippe Beaune, Eric Thervet, et al.
Clinical Transplants
|
June 24, 2011
Bortezomib alone fails to decrease donor specific anti-HLA antibodies: even after one year post-treatment
Rebecca Sberro-Soussan, Julien Zuberl, Caroline Suberbielle-Boissel, et al.
Transplantation
|
July 30, 2014
Diarrhea after kidney transplantation: a new look at a frequent symptom
Florence Aulagnon, Anne Scemla, Susan DeWolf, et al.
Transplantation Direct
|
December 28, 2020
COVID-19: A One-center Experience in Paris
Nathalie Chavarot, Catherine Fournier, Carole Burger, et al.
Lancet (London, England)
|
April 30, 2013
Diagnostic criteria for kidney transplant rejection: a call to action - Authors' reply
Alexandre Loupy, Carmen Lefaucheur, Denis Glotz, et al.
Nephrologie & Therapeutique
|
July 16, 2011
[Parvovirus B19 infection after kidney transplantation]
Albane Brodin-Sartorius, Yahia Mekki, Bénédicte Bloquel, et al.
Transplantation
|
May 29, 2004
Complications of protocol renal biopsy
Lazaro Capote Fereira, Alexandre Karras, Frank Martinez, et al.
Transplantation
|
November 30, 2005
Proteinuria following a switch from calcineurin inhibitors to sirolimus
Emmanuel Letavernier, Marie-Noëlle Pe'raldi, Antoine Pariente, et al.
Page
of 46